China Ban On Genetic Testing Throws Pall Over Research Community
This article was originally published in PharmAsia News
China's recent ban on genetic testing for any purpose, including all medical diagnostics, has raised concerns the country may fall behind in cutting-edge genetic research while the work spreads in other countries.
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.